A summary of the status of the Company’s
outstanding stock options and changes during the year is presented below:
| Schedule of options activity | |
| | | |
| | | |
| | | |
| | |
| | |
Number of
Options | | |
Weighted
Average
Exercise
Price | | |
Weighted
Average
Remaining
Contract
Term | | |
Aggregate
Intrinsic
Value | |
| Outstanding at December 31, 2023 | |
| 21,330,000 | | |
$ | 0.08 | | |
| 9.74 | | |
$ | – | |
| Granted | |
| – | | |
$ | – | | |
| – | | |
$ | – | |
| Cancelled | |
| (1,500,000 | ) | |
$ | – | | |
| – | | |
$ | – | |
| Exercised | |
| – | | |
$ | – | | |
| – | | |
$ | – | |
| Outstanding at December 31, 2024 | |
| 19,830,000 | | |
$ | 0.08 | | |
| – | | |
$ | – | |
| Granted | |
| – | | |
$ | – | | |
| – | | |
$ | – | |
| Cancelled | |
| – | | |
$ | – | | |
| – | | |
$ | – | |
| Exercised | |
| – | | |
$ | – | | |
| – | | |
$ | – | |
| Outstanding at March 31, 2025 | |
| 19,830,000 | | |
$ | 0.08 | | |
| – | | |
$ | – | |
| Exercisable at March 31, 2025 | |
| 13,030,000 | | |
$ | 0.08 | | |
| 7.9 | | |
$ | – | |
| Schedule of stock options activity number of shares |
|
|
|
|
|
|
Range of Exercise
Prices |
|
Number Outstanding
3/31/2025 |
|
Weighted Average
Remaining
Contractual Life |
|
Weighted Average
Exercise Price |
| $0.06 – $0.39 |
|
19,830,000 |
|
7.9 years |
|
$0.08 |